Clinical Trial Information Request for Protocol 23-235 Title A Phase 1 Study of the Polymerase Theta (POL?) Inhibitor Novobiocin in BRCA-mutant and Other DNA Damage Repair-Deficient Solid Tumors PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone